Exclusive: Damning report urges Trump admin to do more to stop ‘dangerous trans agenda’

The American Principles Project (APP) is calling on the Trump administration to take additional steps to protect children from dangerous sex change procedures, according to a report first obtained by the Daily Caller News Foundation.

The APP’s report says that amid the “rapid proliferation” of so-called “gender-affirming care” — particularly among minors — the “gender-industrial complex” has played “an elaborate game of hide-the-ball to avoid political and legal accountability.”

“There must be justice for those who have fallen victim to the gender ‘medicine’ industry’s lies and destructive practices,” APP President Terry Schilling said in a statement provided to the DCNF. “In our report, we’ve outlined several additional ways the Trump administration can protect the vulnerable from the dangerous trans agenda and hold the $4.5 billion gender industry accountable. It’s time to put an end to this once and for all!”

The transgender industry has been “booming” in recent years, according to the report. The report found that over the past decade, the number of people undergoing medicalized gender transition has “skyrocketed,” while the number of detransitioners — people who desist from identifying as transgender — has similarly risen.

The Trump administration has been moving to crack down on gender ideology this year, including the Department of Justice (DOJ) issuing a memo in May aiming to prevent “the mutilation of American children.” Additionally, the Department of Health and Human Services (HHS) published a review in May that outlined the lack of scientific evidence supporting the use of “gender-affirming” care for children experiencing gender dysphoria.

Between 2019 and 2023, 13,994 minors notably underwent sex change treatments in the U.S., according to the Stop The Harm Database.

Moreover, the APP’s report calls on the U.S. Food and Drug Administration (FDA) to consider commissioning a long-term systematic review of off-label drug use (OLDU) of puberty blockers for minors. APP also stated in the report that they believe the FDA should also freeze all pending requests for permission to conduct trials on the use of cross-sex hormones in “gender-affirming care” for minors and also require serious warning labels on all such drugs.

Additionally, the report suggests that the Federal Trade Commission (FTC) should impose orders on “gender-affirming care” providers who are found guilty of “making deceptive representations regarding the efficacy and safety of these services or who fail to disclose the potential risks and experimental nature of the relevant procedures.”

All republished articles must include our logo, our reporter’s byline, and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact licensing@dailycallernewsfoundation.org.

DONATE TO BIZPAC REVIEW

Please help us! If you are fed up with letting radical big tech execs, phony fact-checkers, tyrannical liberals and a lying mainstream media have unprecedented power over your news please consider making a donation to BPR to help us fight them. Now is the time. Truth has never been more critical!